By Conor Coyle
Date: Tuesday 06 Sep 2016
(ShareCast News) - US manufacturing company Danaher Corp. is set to buy molecular diagnostics firm Cepheid in a deal worth around $4bn including debt.
No recent information was found.
Currency | US Dollars |
Share Price | $ 189.90 |
Change Today | $ -0.57 |
% Change | -0.30 % |
52 Week High | $280.76 |
52 Week Low | $174.64 |
Volume | 95 |
Shares Issued | 719.10m |
Market Cap | $136,557m |
Beta | 0.93 |
RiskGrade | 135 |
Strong Buy | 12 |
Buy | 9 |
Neutral | 4 |
Sell | 0 |
Strong Sell | 0 |
Total | 25 |
Time | Volume / Share Price |
15:59 | 100 @ $189.80 |
15:59 | 100 @ $189.87 |
15:59 | 150 @ $189.85 |
15:59 | 100 @ $189.87 |
15:59 | 100 @ $189.86 |
You are here: research